Keane WF - Search Results

1

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators. Brenner BM, et al. Among authors: keane wf. N Engl J Med. 2001 Sep 20;345(12):861-9. doi: 10.1056/NEJMoa011161. N Engl J Med. 2001. PMID: 11565518 Free article. Clinical Trial.

2

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.

Bakris GL, Whelton P, Weir M, Mimran A, Keane W, Schiffrin E. Bakris GL, et al. J Clin Pharmacol. 2000 Aug;40(8):815-25. doi: 10.1177/00912700022009549. J Clin Pharmacol. 2000. PMID: 10934665

3

Proteinuria: its clinical importance and role in progressive renal disease.

Keane WF. Keane WF. Am J Kidney Dis. 2000 Apr;35(4 Suppl 1):S97-105. doi: 10.1016/s0272-6386(00)70237-x. Am J Kidney Dis. 2000. PMID: 10766008 Review.

4

Diabetes in the elderly population.

Khan MA, Collins AJ, Keane WF. Khan MA, et al. Among authors: keane wf. Adv Ren Replace Ther. 2000 Jan;7(1):32-51. doi: 10.1016/s1073-4449(00)70004-5. Adv Ren Replace Ther. 2000. PMID: 10672916 Review.

5

The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats.

Crary GS, Swan SK, O'Donnell MP, Kasiske BL, Katz SA, Keane WF. Crary GS, et al. Among authors: keane wf. J Am Soc Nephrol. 1995 Oct;6(4):1295-9. doi: 10.1681/ASN.V641295. J Am Soc Nephrol. 1995. PMID: 8589300 Free article.

6

Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.

Abraham PA, Opsahl JA, Halstenson CE, Keane WF. Abraham PA, et al. Among authors: keane wf. Arch Intern Med. 1988 Nov;148(11):2358-62. Arch Intern Med. 1988. PMID: 2847667

7

The long-term tolerability of enalapril in hypertensive patients with renal impairment.

Keane WF, Polis A, Wolf D, Faison E, Shahinfar S. Keane WF, et al. Nephrol Dial Transplant. 1997;12 Suppl 2:75-81. Nephrol Dial Transplant. 1997. PMID: 9269706 Clinical Trial.

8

Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.

Hirata-Dulas CA, Rith-Najarian SJ, McIntyre MC, Ross C, Dahl DC, Keane WF, Kasiske BL. Hirata-Dulas CA, et al. Among authors: keane wf. Clin Nephrol. 1996 Aug;46(2):92-8. Clin Nephrol. 1996. PMID: 8869785

9

Proteinuria and cardiovascular disease.

Weinstock Brown W, Keane WF. Weinstock Brown W, et al. Among authors: keane wf. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S8-S13. doi: 10.1053/ajkd.2001.27383. Am J Kidney Dis. 2001. PMID: 11576914 Review.

10

Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.

Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, Shahinfar S, Snapinn SM, Toto R, Brenner BM; RENAAL Study Investigators. Keane WF, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):761-7. doi: 10.2215/CJN.01381005. Epub 2006 May 17. Clin J Am Soc Nephrol. 2006. PMID: 17699284 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results